Evidence map›Paper›PMID 38973935›Full record

ArticleACS omega2024

An Optimized and Universal Protocol for the Synthesis of Morpholine-2,5-Diones from Natural Hydrophobic Amino Acids and Their Mixture.

Tobias F Burton, Zoé Garisoain, Caroline Chaix, Joris Aassine, Emilie Virapin, Anna Voronova, Julien Pinaud, Olivia Giani

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cyclooctyne End-Functionalized Poly(morpholine-2,5-dione)s.Macromolecular rapid communications · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tobias F BurtonICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID https://orcid.org/0000-0002-2422-9585
Zoé GarisoainICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Caroline ChaixICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Joris AassineICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Emilie VirapinICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
Anna VoronovaICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID https://orcid.org/0000-0001-5883-820X
Julien PinaudICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID https://orcid.org/0000-0003-4446-3771
Olivia GianiICGM, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.ORCID https://orcid.org/0000-0002-1833-2324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morpholine-2,5-diones (MDs) are increasingly attractive compounds that can be produced using amino acid (AA) as a starting material. These compounds can undergo polymerization to produce biodegradable materials, namely, polydepsipeptides, that hold the potential to be used in medicinal applications. In this study, a simplified yet high-yield MD synthesis procedure was developed and applied to produce a range of MDs derived from hydrophobic AAs including Leu, Ile, Val, Phe, Asp(OBzl), Lys(Z), and Ser(tBu). Moreover, using a blend of hydrophobic amino acids (Leu, Ile, Val, and Phe), mixtures of MDs could be synthesized simultaneously. Finally, the polymerization of these MD mixtures was probed and proven successful. The concept investigated herein constitutes a novel path toward the valorization of protein-rich waste by producing renewable and biodegradable materials.

Identifiers

PMID38973935
PMCPMC11223217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.